glp 1 patches while breastfeeding Do GLP-1 Really Work? Evidence and FDA-Approved Alternatives No Doctor Recommends Taking Ozempic

GLP-1R as a target for the treatment of diabetic retinopathy: friend or foe

For people with type 2 diabetes, the STEP-2 trial showed average weight loss of around 9.6% on the 2.4mg dose, roughly 64% of the result in people without diabetes 4

Global Mounjaro Market Size and Forecast The Global Mounjaro Market is estimated to be valued at USD 19.93 Bn in 2026 and is expected to reach USD 66.58 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 18.8% from 2026 to 2033

The real impact will depend on how rebate structures and formulary positioning adjust in response

PDGF signalling controls age-dependent proliferation in pancreatic beta-cells

Dosing Comparison# Retatrutide Dosing# Based on Phase 2 clinical trial protocols (investigational only): Starting dose : 0.5 mg weekly subcutaneous injection Escalation : Gradual increase over 12-24 weeks to target dose (up to 12 mg) Target doses tested : 1, 4, 8, and 12 mg weekly Escalation rationale : Extended 24-week escalation for higher doses reduces GI side effects compared to faster 12-week escalation No commercial formulation exists